Email this article ABOUT THE POSSIBILITY OF TOXIC EFFECTS DEVELOPING IN CONTACT WITH N-NITROSOALKYLUREA DERIVATIVE - LYSOMUSTINE
- Authors: Stosman K.I.1, Lukovnikova L.V.1, Sidorin G.I.1, Dyakova L.I.1, Zatsepin E.P.1, Shestova G.V.1, Litvintsev B.S.1
-
Affiliations:
- Institute of Toxicology of the Federal Medical Biological Agency
- Issue: No 4 (2020)
- Pages: 34-38
- Section: Articles
- Published: 31.07.2020
- URL: https://rjpbr.com/0869-7922/article/view/641253
- DOI: https://doi.org/10.36946/0869-7922-2020-3-4-34-38
- ID: 641253
Cite item
Full Text
Abstract
The paper presents the results of a study on the possibility of toxic effects developing in contact with the antitumor drug – lysomustine - to assess the health risk in the manufacture of the finished dosage form and its use. The work was performed on 40 outbred rats, 40 guinea pigs and 114 outbred mice. The experimental study has showed that lysomustine does not irritate intact skin, is not a potential allergen, has no skin-resorptive effect, does not cause reproductive disorders. The drug reveales mutagenic properties inherent in many cytostatics, representatives of the class of N-nitrosoalkylureas. The research results allow to conclude that the presence of the drug in the air of industrial premises and on the skin of workers in its manufacture and use of the finished dosage form is unacceptable.
About the authors
K. I. Stosman
Institute of Toxicology of the Federal Medical Biological Agency
Author for correspondence.
Email: kira.stosman@influenza.spb.ru
Stosman Kira Iosiphovna
192019, Saint Petersburg
Russian FederationL. V. Lukovnikova
Institute of Toxicology of the Federal Medical Biological Agency
Email: lukovnikova.l.v@toxicology.ru
Lukovnikova Lubov Vladimirovna
192019, Saint Petersburg
Russian FederationG. I. Sidorin
Institute of Toxicology of the Federal Medical Biological Agency
Email: sidorin.g@mail.ru
Sidorin Gennadij Ivanovich
192019, Saint Petersburg
Russian FederationL. I. Dyakova
Institute of Toxicology of the Federal Medical Biological Agency
Email: fake@neicon.ru
Dyakova Lyudmila Ivanovna
192019, Saint Petersburg
Russian FederationE. P. Zatsepin
Institute of Toxicology of the Federal Medical Biological Agency
Email: fake@neicon.ru
Zatsepin Eduard Pavlovich
192019, Saint Petersburg
Russian FederationG. V. Shestova
Institute of Toxicology of the Federal Medical Biological Agency
Email: fake@neicon.ru
Shestova Galina Vladimirovna
192019, Saint Petersburg
Russian FederationB. S. Litvintsev
Institute of Toxicology of the Federal Medical Biological Agency
Email: fake@neicon.ru
Litvintsev Bogdan Sergeevich
192019, Saint Petersburg
Russian FederationReferences
- Gorohova L.G., Martynova N.A., Kizichenko N.V., Logunova T.D. Hygienic aspects of the health status of workers in the chemical and pharmaceutical industry. Medicine in Kuzbass. 2017; 16(3): 11-16 (in Russian).
- Imankulova B.N., Dzhusupov K.O. The influence of the chemical factor of the working environment on the health of medical personnel in an oncology clinic. Bulletin of I.K. Akhunbaev Kyrgyz State Medical Academy. 2016; 5: 85 – 91 (in Russian).
- Bagirova B.L., Ryshkova N.E., Oborotova N.A. A new dosage form of the antitumor drug bis-chloroethyl-nitrosourea. Vedomosti NC EGKPS. 1999;1: 15-19 (in Russian).
- Margaeva M.P., Karpova E.V. Factors affecting the health status of medical workers. Nurse. 2015; 6: 48-58 (in Russian).
- Ramphal R., Bains T., Goulet G., Vaillancourt R. Occupational exposure to chemotherapy of pharmacy personnel at a single centre. CJHP. 2015; 68 (2): 104 - 112.
- Connor T.H., DeBord D.G., Pretty J.R. et al. Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. J. Occup. Environ Med. 2010; 52: 1019–1027.
- Alavi N.M. Occupational Hazards in Nursing. Nurs Midwifery Stud. 2014; 3 (3): 223-257.
- Tyulyandin S.A., Samojlenko I.V., Izmerova N.I., Kuz’mina L.P., Koroleva E.P., Tihonova G.I. Guidelines for medical personnel on the safe handling of anticancer drugs. Moscow; 2012 (in Russian).
- Walton A.M.L., Mason S., Busshart M., Spruill A.D. et al. Safe Handling: Implementing Hazardous Drug Precautions. Clin J Oncol Nurs. 2012; 16 (3): 251-254.
- Janes A., Tanguay C., Caron J., Bussieres J-F. Environmental contamination with cyclophosphamide, ifosfamide, and methotrexate: a study of 51 canadian centres. Can J Hosp Pharm. 2015; 68 (4): 279-89.
- Solenova L.G., Yakubovskaya M.G. Chemotherapy: possible risks during handling anticancer drugs. Advances in molecular oncology. 2017; 4 (3): 10-20 (in Russian).
- Directive 2010/63/EU of the European Parliament and of the Council of the European Union for the protection of animals used for scientific purposes. SPb.;2012.
- Guidelines for preclinical studies of drugs. Part 1. M.: Grif & K; 2012 (in Russian).
- Requirements for the formulation of experimental studies to substantiate the maximum permissible concentrations of industrial chemical allergens in the air of the working zone and atmosphere. Methodological guidelines. MU 1.1.578-96; 2014 (in Russian).
- Sanock I.V. Methods for determining the toxicity and hazard of chemicals (toxicometry). M.: Medicina; 1970 (in Russian).
- Tikhonova G.I., Rubtsova N.B., Yakovleva T.P. Working conditions of parents as a risk factor for the development of congenital malformations in children. Life Safety. 2006;(2):52–7 (in Russian).
- Shirangi A., Bower C., Holman C.D. et al. A study of handling cytotoxic drugs and risk of birth defects in offspring of female veterinarians. Int J Environ Res Public Health. 2014; 11(6): 6216–30.
- Agents classified by the IARC MONOGRAPHS, 1-117. Available at: http://monographs.iarc.fr/ENG/Classification.
Supplementary files
